Search alternatives:
linear decrease » linear increase (Expand Search)
market decrease » marked decrease (Expand Search), largest decrease (Expand Search), marked increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
a linear » _ linear (Expand Search)
a market » _ market (Expand Search), a marker (Expand Search)
linear decrease » linear increase (Expand Search)
market decrease » marked decrease (Expand Search), largest decrease (Expand Search), marked increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
a linear » _ linear (Expand Search)
a market » _ market (Expand Search), a marker (Expand Search)
-
1
-
2
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin...
Published 2025“…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
-
3
Algorithm operation steps.
Published 2025“…Experimental results demonstrate that SCI-YOLO11 achieves a 3.2% improvement over baseline models in terms of MAP@0.5 metric; precision and recall rates increase by 2.6% and 3.7%, respectively. Additionally, its parameter count and floating-point operations decrease by 6% and 7.9%, respectively. …”
-
4
Store listing metrics and user acquisition.
Published 2025“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”
-
5
Installation, growth, and retention metrics.
Published 2025“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”
-
6
Implemented activities.
Published 2025“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”
-
7
App user retention trends.
Published 2025“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”
-
8
App user onboarding trends.
Published 2025“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”
-
9
App user base growth trends.
Published 2025“…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Uganda 2023 NCD risk factor STEPS survey data.
Published 2025“…The risk factor prevalences that increased significantly were: high blood glucose from 1.5% in 2014 to 3.3% in 2023 (p< 0.001); overweight and obesity from 19.3% in 2014 to 24.1% in 2023 (p< 0.001); current alcohol consumption from 28.5% in 2014 to 31.1% in 2023 (p=0.013); and sedentariness from 26.6% in 2014 to 31.9% in 2023 (p< 0.001). The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”
-
17
Uganda 2014 NCD risk factor STEPS survey data.
Published 2025“…The risk factor prevalences that increased significantly were: high blood glucose from 1.5% in 2014 to 3.3% in 2023 (p< 0.001); overweight and obesity from 19.3% in 2014 to 24.1% in 2023 (p< 0.001); current alcohol consumption from 28.5% in 2014 to 31.1% in 2023 (p=0.013); and sedentariness from 26.6% in 2014 to 31.9% in 2023 (p< 0.001). The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”
-
18
-
19
-
20